publication venue for
- Heart Failure Events After Long-term Continuous Screening for Atrial Fibrillation: Results From the Randomized LOOP Study. 17:e012764. 2024
- Colchicine to Prevent Atrial Fibrillation Recurrence After Catheter Ablation: A Randomized, Placebo-Controlled Trial. 17:e01238. 2024
- Advances in Cardiac Electrophysiology. 15:e009911. 2022
- Pattern of Atrial Fibrillation and Cognitive Function in Young Patients With Atrial Fibrillation and Low CHADS 2 Score: Insights From the BRAIN-AF Trial. 15:e010462. 2022
- Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the ADRB1 Arg389Arg Genotype. 14:e009591. 2021
- Cardiac Resynchronization Therapy With or Without Defibrillation in Patients With Nonischemic Cardiomyopathy: A Systematic Review and Meta-Analysis. 14:e008991. 2021
- Active-Fixation Atrial Leads and the Risk of Atrial Fibrillation. 13:e008655. 2020
- Canakinumab After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation. 13:e008197. 2020
- Impact of Cardiac Implantable Electronic Device Infection. 13:e008280. 2020
- Genetic Susceptibility for Atrial Fibrillation in Patients Undergoing Atrial Fibrillation Ablation. 13:e007676. 2020
- Major Adverse Cardiovascular Events Associated With Postoperative Atrial Fibrillation After Noncardiac Surgery. 13:e007437. 2020
- Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma. 12:e007545. 2019
- Letter by Belley-Côté et al Regarding Article, “Randomized Controlled Trial of Surgical Versus Catheter Ablation for Paroxysmal and Early Persistent Atrial Fibrillation”. 12:e007036. 2019
- Differentiating Ventricular From Supraventricular Arrhythmias Using the Postpacing Interval After Failed Antitachycardia Pacing. 11:e005921. 2018
- Loss-of-Function KCNE2 Variants. 10:e005282. 2017
- Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients. 10:e004875. 2017
- Relationships of Measured and Genetically Determined Height With the Cardiac Conduction System in Healthy Adults. 10:e004735. 2017
- Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation. 10:e004267. 2017
- Canadian Registry of Implantable Electronic Device Outcomes. 9:e004282. 2016
- Cardiac Abnormalities in First-Degree Relatives of Unexplained Cardiac Arrest Victims. 9:e004274. 2016
- Resolving Myocardial Activation With Novel Omnipolar Electrograms. 9:e004107. 2016
- Frequency and Outcomes of Postrandomization Atrial Tachyarrhythmias in the Resynchronization/Defibrillation in Ambulatory Heart Failure Trial. 9:e003807. 2016
- Response to Letter Regarding Article, “Outcome of Apparently Unexplained Cardiac Arrest: Results From Investigation and Follow-Up of the Prospective Cardiac Arrest Survivors With Preserved Ejection Fraction Registry”. 9:e004012. 2016
- Outcome of Apparently Unexplained Cardiac Arrest. 9:e003619. 2016
- Incidence, Predictors, and Procedural Results of Upgrade to Resynchronization Therapy. 8:152-158. 2015
- Interaction Between Digoxin and Dronedarone in the PALLAS Trial. 7:1019-1025. 2014
- Is Defibrillation Testing Necessary for Implantable Transvenous Defibrillators?. 7:347-351. 2014
- Outcome of Ventricular Tachycardia Ablation in Patients With Nonischemic Cardiomyopathy. 6:513-521. 2013
- Modification of Outcomes With Aspirin or Apixaban in Relation to CHADS 2 and CHA 2 DS 2 -VASc Scores in Patients With Atrial Fibrillation. 6:31-38. 2013
- Epinephrine Infusion in the Evaluation of Unexplained Cardiac Arrest and Familial Sudden Death. 5:933-940. 2012
- Relevance of Electrical Remodeling in Human Atrial Fibrillation. 5:626-631. 2012
- Predictors of Short-Term Complications After Implantable Cardioverter-Defibrillator Replacement. 4:136-142. 2011
- Utility of Treadmill Testing in Identification and Genotype Prediction in Long-QT Syndrome. 3:120-125. 2010